Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

NCT05300035 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

69

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV/AIDS and Infections

Interventions

DRUG: Recombinant human monoclonal antibody (bNAbs)
DRUG: Placebo

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]